Literature DB >> 8112438

Self-reported prevalence of asthma symptoms in children in Australia, England, Germany and New Zealand: an international comparison using the ISAAC protocol.

N Pearce1, S Weiland, U Keil, P Langridge, H R Anderson, D Strachan, A Bauman, L Young, P Gluyas, D Ruffin.   

Abstract

There is a need for a standardized approach to international and regional comparisons of the prevalence and severity of asthma, and for the monitoring of asthma morbidity over time. In 1991, standardized written and video questionnaires were developed and administered in surveys of schoolchildren, aged 12-15 yrs, in five regions in four countries: Adelaide, Australia (n = 1,428); Sydney, Australia (n = 1519); West Sussex, England (n = 2,097); Bochum, Germany (n = 1928); and Wellington, New Zealand (n = 1863). The self-reported prevalence of wheezing during the previous 12 months was similar in West Sussex (29% using the written questionnaire and 30% using the video questionnaire), Wellington (28 and 36%), Adelaide (29 and 37%), and Sydney (30 and 40%), but was lower in Bochum (20 and 27%). The one year prevalence of severe wheezing limiting speech was greater in Wellington (11%), Adelaide (10%) and Sydney (13%), than in West Sussex (7%) and Bochum (6%). The self-reported one year prevalences of frequent attacks, frequent nocturnal wheezing, and doctor diagnosed asthma, were also higher in the Australasian centres than in the European centres. We conclude, that an international comparison of asthma symptom prevalence in childhood, using simple standardized instruments, is feasible. Possible explanations for the differences in reported asthma severity between the Australasian and European centres include differences in exposure to risk factors and differences in the management of asthma.

Entities:  

Mesh:

Year:  1993        PMID: 8112438

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  49 in total

1.  Using Medicaid data to estimate state- and county-level prevalence of asthma among low-income children.

Authors:  P A Buescher; K Jones-Vessey
Journal:  Matern Child Health J       Date:  1999-12

2.  Socioeconomic risk factors in the prevalence of asthma and other atopic diseases in children 6 to 7 years old in Valencia Spain.

Authors:  M M Suárez-Varela; A L González; M I Martínez Selva
Journal:  Eur J Epidemiol       Date:  1999-01       Impact factor: 8.082

3.  Acute effects of winter air pollution on respiratory function in schoolchildren in southern England.

Authors:  J L Peacock; P Symonds; P Jackson; S A Bremner; J F Scarlett; D P Strachan; H R Anderson
Journal:  Occup Environ Med       Date:  2003-02       Impact factor: 4.402

4.  Continuing decline in acute asthma episodes in the community.

Authors:  R S Sunderland; D M Fleming
Journal:  Arch Dis Child       Date:  2004-03       Impact factor: 3.791

5.  Evaluation of bronchial responsiveness to exercise in children as an objective measure of asthma in epidemiological surveys.

Authors:  J V West; C F Robertson; R Roberts; A Olinsky
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

Review 6.  Air pollution: brown skies research.

Authors:  A E Tattersfield
Journal:  Thorax       Date:  1996-01       Impact factor: 9.139

7.  A longitudinal test of the theory of planned behavior predicting smoking onset among asthmatic and non-asthmatic adolescents.

Authors:  Monique O M Van De Ven; Rutger C M E Engels; Roy Otten; Regina J J M Van Den Eijnden
Journal:  J Behav Med       Date:  2007-06-30

Review 8.  Environmental risk factors for atopy.

Authors:  B Björkstén
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

9.  [Smoking among children and adolescents: a challenge for primary prevention].

Authors:  S K Weiland; S Stolpe; U Keil
Journal:  Soz Praventivmed       Date:  1994

10.  Comparison of allergic diseases, symptoms and respiratory infections between Finnish and Russian school children.

Authors:  Timo Hugg; Risto Ruotsalainen; Maritta S Jaakkola; Vadim Pushkarev; Jouni J K Jaakkola
Journal:  Eur J Epidemiol       Date:  2008-01-17       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.